Phase 2 trial of ATX-GD-59 in the patients with Graves' disease.
Phase of Trial: Phase II
Latest Information Update: 19 Mar 2018
At a glance
- Drugs ATX-GD 59 (Primary)
- Indications Graves' disease
- Focus Therapeutic Use
- 19 Mar 2018 According to an Apitope website (https://apitope.com/graves-disease/), this trial is expected to initiate in the first quarter of 2019.
- 19 Mar 2018 New trial record